Showing page 1 of 27 pages of list content

  1. Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in children

    This article has 32 authors:
    1. Hamtandi M. Natama
    2. Jo Salkeld
    3. Athanase Somé
    4. Seyi Soremekun
    5. Salou Diallo
    6. Ousmane Traoré
    7. Toussaint Rouamba
    8. Florence Ouédraogo
    9. Edouard Ouédraogo
    10. K. Carine Sonia Daboné
    11. Nadine A. Koné
    12. Z. Michael John Compaoré
    13. Miguel Kafando
    14. Massa dit Achille Bonko
    15. Fabé Konaté
    16. Hermann Sorgho
    17. Carolyn M. Nielsen
    18. Dimitra Pipini
    19. Ababacar Diouf
    20. Lloyd D. W. King
    21. Umesh Shaligram
    22. Carole A. Long
    23. Jee-Sun Cho
    24. Alison M. Lawrie
    25. Katherine Skinner
    26. Rachel Roberts
    27. Kazutoyo Miura
    28. John Bradley
    29. Sarah E. Silk
    30. Simon J. Draper
    31. Halidou Tinto
    32. Angela M. Minassian

    Reviewed by PREreview

    This article has 2 evaluationsAppears in 1 listLatest version Latest activity
  2. Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays

    This article has 8 authors:
    1. Jonathan G Van Vranken
    2. Jiaming Li
    3. Julian Mintseris
    4. Ting-Yu Wei
    5. Catherine M Sniezek
    6. Meagan Gadzuk-Shea
    7. Steven P Gygi
    8. Devin K Schweppe
    This article has been curated by 1 group:
    • Curated by eLife

      eLife Assessment

      The study provides a valuable showcase of a workflow to perform large-scale characterization of drug mechanisms of action using proteomics in which on-target and off-targets of 166 compounds using proteome solubility analysis in living cells and cell lysates were determined. The evidence supporting the claims of the authors is solid, however, the inclusion of more replicate experiments and more statistical rigor would have strengthened the study. This will be of broad interest to medicinal chemists, toxicologists, computational biologists and biochemists.

    Reviewed by PREreview, eLife

    This article has 9 evaluationsAppears in 2 listsLatest version Latest activity
  3. Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases

    This article has 21 authors:
    1. Anna Shemorry
    2. Willem den Besten
    3. Melinda M. Mulvihill
    4. Curt J. Essenburg
    5. Nicole Blaquiere
    6. Tracy Kleinheinz
    7. Elisia Villemure
    8. Frank Peale
    9. Gauri Deshmukh
    10. Danilo Maddalo
    11. Elizabeth Levy
    12. Kebing Yu
    13. Elizabeth A. Tovar
    14. Emily Wolfrum
    15. Robert A. Blake
    16. Karthik Nagapudi
    17. William F. Forrest
    18. Steven T. Staben
    19. Carrie R. Graveel
    20. Wayne J. Fairbrother
    21. Ingrid E. Wertz

    Reviewed by PREreview

    This article has 1 evaluationAppears in 1 listLatest version Latest activity